Levels of soluble interleukin-2 receptors are predictive of response in patients treated with interleukin-2 and lymphokine-activated killer cells
Authors:
- 1 June 1995
- journal article
- research article
- Published by Springer Nature in Medical Oncology
- Vol. 12 (2) , 121-124
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The IL-2/IL-2 receptor system: A current overviewCell, 1993
- High serum and ascitic soluble interleukin-2 receptor alpha levels in advanced epithelial ovarian cancer.1993
- Serum CD25 Levels During Interleukin-2 TherapyJournal of Immunotherapy, 1992
- Biological monitoring of low-dose interleukin 2 in humans: soluble interleukin 2 receptors, cytokines, and cell surface phenotypes.1991
- Serum soluble interleukin-2 (IL-2) receptor levels in women with breast carcinoma and its correlation with IL-2 receptor expression on blood lymphocytes and lymphocytic infiltration within the tumourCancer Immunology, Immunotherapy, 1991
- SERUM SOLUBLE INTERLEUKIN-2 RECEPTOR IS ASSOCIATED WITH CLINICAL AND PATHOLOGICAL DISEASE STATUS IN HAIRY-CELL LEUKEMIA1990
- The Soluble Interleukin-2 Receptor: Biology, Function, and Clinical ApplicationAnnals of Internal Medicine, 1990
- THE SOLUBLE INTERLEUKIN‐2 RECEPTOR IN HAEMATOLOGICAL DISORDERSBritish Journal of Haematology, 1987
- Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival.Journal of Clinical Oncology, 1987
- Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.The Journal of Immunology, 1985